CHICAGO--(BUSINESS WIRE)--Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a ...

Transformative, non-invasive technology provides real-time insights into cardiac performance and fluid status, enabling clinicians to optimize heart failure treatment earlier than ever and improve ...

toSense’s CoVa Monitoring System 2, a remote patient monitoring necklace that tracks vitals and cardiac fluids, has received a second FDA clearance. The new clearance will allow the company to update ...

Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leverages proprietary algorithms and proven technologies to ...

Health: Sensydia’s noninvasive cardiac assessment platform on a patient. Westwood-based Sensydia Corp., which is developing a non-invasive cardiac assessment platform, has received a $3 million grant ...